Search

everythinglearnresearchcommunity

for

Search:↓

Oral Apremilast effectively treats alopecia areata in most patients.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

Kids with alopecia areata had lower vitamin D levels than healthy kids.

Too much epidermal growth factor can cause hair loss.

Achieving 80% or more scalp hair regrowth is considered a successful treatment for significant hair loss.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

COVID-19 doesn't make alopecia areata worse.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Children with autoimmune hair loss have similar vitamin D levels to healthy kids, suggesting no extra screening is needed.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

The document suggests using a topical Vitamin D treatment for hair loss rather than oral supplements and calls for more research.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Researchers created a fast, accurate computer program to measure hair loss in alopecia areata patients.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

This therapy effectively treats resistant alopecia areata with minimal side effects.

Bimatoprost may help treat hair loss from alopecia areata.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Combining pulsed prednisone with tofacitinib can lead to lasting hair regrowth in severe alopecia areata patients.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.